# LAMOTRIGINE
> **ANDA202887** · Abbreviated New Drug Application (Generic) · Sponsor: RUBICON RESEARCH · Approved 2013-06-17
## Drug
- **FDA Application Number:** ANDA202887
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LAMOTRIGINE
- **Generic name:** Lamotrigine
- **Active ingredients:** LAMOTRIGINE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** RUBICON RESEARCH
- **First approval:** 2013-06-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202887)
---
*AI Analytics · CC0 1.0*